Gabriela Elis Wachholz1,2,3†
Bruna Duarte Rengel
Neil Vargesson
Lucas Rosa Fraga- 1Postgraduate Program of Genetics and Molecular Biology, Department of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
- 2Laboratory of Genomic Medicine, Experimental Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
- 3Teratogen Information Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
- 4School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom
- 5Department of Morphological Sciences, Institute of Health Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
- 6Postgraduate Program in Medicine: Medical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
Congenital anomalies and its causes, particularly, by external factors are the aim of the field called teratology. The external factors studied by teratology are known as teratogens and can be biological or environmental factors for example, chemicals, medications, recreational drugs, environmental pollutants, physical agents (e.g., X-rays and maternal hyperthermia) and maternal metabolic conditions. Proving the teratogenicity of a factor is a difficult task requiring epidemiology studies as well as experimental teratology evidence from the use of animal models, one of which is the chicken embryo. This model in particular has the advantage of being able to follow development live and in vivo, with rapid development hatching around 21 days, is cheap and easy to manipulate and to observe development. All this allows the chicken embryo to be used in drug screening studies, teratogenic evaluation and studies of mechanisms of teratogenicity. The chicken embryo shares morphological, biochemical and genetic similarities with humans as well as mammalian species, making them ideal to ascertain the actions of teratogens, as well as screen drugs to test for their safety. Pre-clinical trials for new drugs are carried out in rodents and rabbits, however, chicken embryos have been used to screen new compounds or analogs of thalidomide as well as to investigate how some drugs can lead to congenital malformations. Indeed, the chicken embryo has proved valuable in understanding how many congenital anomalies, seen in humans, arise following teratogen exposure. The aim of this review is to highlight the role of the chicken embryo as an experimental model for studies in teratology, exploring its use in drug screening studies, phenotypic evaluation and studies of teratogenic mechanisms of action. Here, we discuss many known teratogens, that have been evaluated using the chicken embryo model including some medicines, such as, thalidomide, valproic acid; recreational drugs including alcohol; environmental influences, such as viruses, specifically ZIKV, which is a newly discovered human teratogen. In addition, we discuss how the chicken embryo has provided insight on the mechanisms of teratogenesis of many compounds and also how this impact on drug safety.
Introduction
In humans, data regarding congenital anomalies (CA) induced by teratogens are from observational studies, in which case reports and epidemiological studies indicate an increase of the rate of some malformation and potential risk factors. Due to the fact that CA can cause infant and childhood death, illness and disabilities, it is important to have such methods to allow further investigation of their causes, risk factors and mechanisms [World Health Organization (WHO), 2020a]. Such investigations help directly in the development of strategies to prevent further occurrence, therapeutic interventions and deaths from CAs.
Nowadays many tools and approaches are utilized to study the causes and mechanisms that underlie a CA, from a range of cell culture assays to multiple animal and embryo models. In the context of CA, the chicken embryo model is very relevant since a lot of what is known about embryo development comes from studies with this model (Davey et al., 2018). In addition, many characteristics of the chicken embryo make it very attractive. For example, the chicken embryo offers the advantage of being able to study development live and in vivo throughout gestation (Davey et al., 2018). The chicken embryo also has the advantage of allowing easy administration of chemicals, compounds, external agents that may or are alleged to cause CA to determine their actions upon the embryo. This then allows the study of such CA and enables multiple analyses, genetic and morphological, to be performed in order to understand how the CA was caused and shed light on therapeutic strategies as well as how they could be prevented.
This review aims to highlight the role of the chicken embryo as an experimental model for studies in teratology. For that, we first, review congenital anomalies, teratogenesis, experimental teratogenesis and the advantages of the chicken embryo for such research. Secondly, we discuss examples of how and why the chicken embryo is used for evaluation of risks of exposure to different teratogens, understanding mechanisms of teratogens and also as a tool for preclinical trials in drug screening.
Congenital Anomalies and Teratogenesis—A Review
Congenital Anomalies are structural, metabolic or functional abnormalities existent on birth and can be diagnosed prenatally, at birth or even later [Christianson et al., 2006; World Health Organization (WHO), 2020a]. CAs represent around 25% of infant deaths in the United States of America and 15–39% in Latin America [World Health Organization (WHO), 2020b]. Worldwide, out of 2.5 million deaths of children under 28 days of age in 2017, 283,582 were due to CA [World Health Organization (WHO), 2020b]. Most incidences of CA are from unknown causes, representing 50–75% of all cases [Brent, 2001; World Health Organization (WHO), 2020a]. The known causes are divided into chromosomal and genetic factors, environmental factors, such as exposure to a teratogen or lack of some nutrient in the diet, or a combination between them (Moore et al., 2019). Environmental factors are responsible for around 10% of the anomalies observed (Brent, 2001).
There have been many different approaches in understanding the effects of environmental exposure to the embryo over the past century. An important landmark in teratogenesis (particularly in experimental teratogenesis) was Hale’s publication in 1935. In Hale’s studies, it was reported that pregnant pigs fed with a diet deficient in vitamin A resulted in newborns with congenital malformations (Hale, 1935). These findings were next confirmed in rats by Josef Warkany in 1946, which work underpins the Principles of Teratology postulated first by Wilson (Warkany and Schrafenberger, 1946; Wilson, 1973). From this study, further work in animal models and observations in humans indicated that environmental factors, including maternal conditions, can have important effects upon the development of the embryo and adult disease (Barker and Osmond, 1986; Calkins and Devaskar, 2011). Up until the 1940s, it was thought the placenta worked as a barrier between the embryo/fetus and the outside world, protecting it from environmental agents such as drugs and pathogens. Nevertheless, reports from children whose mothers have had Rubella during pregnancy being born with cataract showed that environmental factors can cross the placenta and damage the embryo (Gregg, 1941).
Environmental factors with the potential of causing CAs in embryos and fetuses exposed during their development are named teratogens. The science that studies the CAs caused by these teratogens and how they affect the embryo by studying pathways and mechanisms that could be caused or altered by them is known as teratology (“teratos” = monster, “logos” = study; Ujházy et al., 2012). A teratogen can be any factor that is extrinsic to embryonic development, such as recreational drugs, medications, biological agents, x-rays and maternal conditions (Brent, 2001; Fraga et al., 2016; Vargesson and Fraga, 2017; Moore et al., 2019). Alcohol, cocaine and nicotine are examples of recreational drugs that are teratogenic (Cambell, 2003; Williams et al., 2015; Holbrook, 2016). Along with recreational drugs, chemicals like mercury, lead and cadmium; medicines like valproic acid, retinoic acid, phenytoin, thalidomide (Gilbert-Barness, 2010; Vargesson and Fraga, 2017); physical agents such as radiation; and maternal conditions such as obesity, pre-eclampsia and hyperthermia, can also be teratogenic (Ferm and Carpenter, 1967; Pleet et al., 1981; Léonard et al., 1983; Bellinger, 1994; Fattibene et al., 1999; Baeten et al., 2001; Gilbert-Barness, 2010; Vargesson and Fraga, 2017).
Perhaps the most famous (or infamous) teratogen is thalidomide and an example of a more recently discovered teratogen is Zika virus (ZIKV). Thalidomide cause a group of malformations in the limbs, heart, eye, ear, and internal organs (Vargesson, 2015), and led to changes in the way medicines are tested and evaluated (Vargesson, 2013). Thalidomide was originally used as a sedative and found to also be effective in treating morning sickness. Thalidomide was thought to be safe. Tragically, more than 10,000 children were born in the late 1950’s and early 1960’s with rare and severe malformations caused by the use of thalidomide during pregnancy (Kim and Scialli, 2011; Vargesson, 2019). More recently, ZIKV is a biological agent, and teratogen, that caused Congenital Zika Syndrome in babies born to mothers who were infected with ZIKV during pregnancy (Rasmussen et al., 2016; Schuler-Faccini et al., 2016). Patients with Congenital Zika Syndrome exhibit microcephaly and other CAs (de Araújo et al., 2016; Marrs et al., 2016; Schuler-Faccini et al., 2016; Del Campo et al., 2017). Children born in areas with no ZIKV have no increased levels of microcephaly.
Experimental Teratogenesis
The classification of an environmental factor as a teratogen is not an easy task. Wilson proposed six principles of teratology to provide a guide to determining and understanding teratogenic agents (Wilson, 1973). These include susceptibility to teratogenesis depends on the genotype, depends on the developmental stage of the embryo, how the teratogen act, the nature of the teratogen and how its absorbed its maternal/placental transfer, proposed different classifications of teratogenic insult (death, malformation, growth retardation, and functional defect) (Wilson, 1973). These principles underpin the field of teratology today. More recently, Shepard (1994) further elaborated the Wilson Principles and proposing additional criteria to guide the process of proving the teratogenicity of a factor in humans, including guidance on clinical and epidemiological findings to indicate if the occurrence of a CA in a population or a cluster of individuals is linked to an environmental influence or exposure.
The history of human teratogenesis shows that it is usually an astute clinician who observes and identifies a potentially teratogenic situation. The demonstration of biological plausibility of the teratogenic potential of a determined exposure is usually determined by in vivo studies, performed through experimental teratology using animal models. In addition, the study of teratogenesis using experimental models is essential to understand how a specific teratogenic agent affects embryonic development in vivo, to help understand the agent and find treatments or prevention of congenital anomalies. Experimental teratogenesis is fundamental to evaluate and understand the mechanisms that lead to the malformations caused by exposure to the agent. Experimental models are also important and useful for drug development when animals are used in preclinical studies to evaluate reproductive and developmental toxicity and evaluation of exposure risk to a specific agent. Studies in animals also allow control of the dose and period of exposure, variables that can apply directly to a teratogenic effect (for example, Mahony et al., 2013; Beedie et al., 2016a, 2017; Cugola et al., 2016; Vargesson and Fraga, 2017).
A wide range of animal models has been used in studies of experimental teratogenesis. The most commonly utilized experimental models are embryos of mice, rats, zebrafish, chicken, rabbit, and non-human primates (for example, Janer et al., 2008; Therapontos et al., 2009; Ema et al., 2010; Ito et al., 2010; Cassina et al., 2012; Mahony et al., 2013; Beedie et al., 2015, 2016a,b; Davey et al., 2018). The choice of the appropriate experimental model depends not only on representing the phenotypes observed in humans but also considers the length of development and the accessibility of the organs and structures potentially affected. Using multiple animal models helps confirm how an alleged teratogen acts and the damage it can cause. Many other factors help in the decision of the most suitable animal model to be used such as facility of manipulation, access to embryo for observation, ethical and founding limitations, species-specificity criteria and susceptibility to the teratogen (Cassina et al., 2012).
Due to the tragedy of thalidomide, for reproductive and developmental toxicity evaluation in preclinical studies, it is now mandatory to use multiple different animal species (Vargesson, 2013). This is important because the sensitivity to some teratogenic agents varies between different species (Janer et al., 2008; Vargesson, 2015). For example, rodents are not very sensitive to thalidomide (Janer et al., 2008; Vargesson, 2015). Interestingly, rodents are also not naturally susceptible to ZIKV infection (Grant et al., 2016), but can be induced to be susceptible (Cairns et al., 2018). The chicken embryo on the other hand is susceptible to thalidomide and also to ZIKV, making it a key model for such studies (Vargesson, 2015; Goodfellow et al., 2016; Willard et al., 2017; Thawani et al., 2018, 2020; Wachholz et al., 2021).
The establishment of experimental models using different teratogens is fundamental since they are essential for the process of understanding the pathways involved and the mechanisms of teratogenesis of each teratogen. Taking into account biological teratogens, such as ZIKV, the experimental models remain indispensable during the process of development of a drug that can treat or prevent any damage caused by exposure during pregnancy.
The Chicken Embryo
The chicken embryo (Gallus gallus; Figure 1) has been used for more than two millennia as an experimental model for studies in a wide range of fields including naturalism, art, philosophy and the beginning of biological sciences trying to answer the most fundamental questions of life, for example how an embryo form (Stern, 2004). For instance, chicken embryo development was first studied in the Egyptian era around 300 BC, and by the Greek scientist, Aristoteles who performed studies focused on anatomy and embryo morphology. Even Leonardo da Vinci used chicken embryos to explore anatomy and embryo development (Stern, 2004). During the last 50 years, in particular, studies with chicken embryos have being contributing to the knowledge about some of the most important concepts in developmental biology particularly in limb development and nervous system development and more recently drug safety (Vargesson et al., 1997; Lewandoski et al., 2000; Stern, 2004; Davey and Tickle, 2007; Towers and Tickle, 2009; Vergara and Canto-Soler, 2012; Mahony and Vargesson, 2013; Beedie et al., 2016a,b; Davey et al., 2018). Indeed, the chicken embryo was fundamental to the work of the neurobiologist Rita Levi-Montalcini who won a Nobel Prize in 1986. The chicken embryo was also one of the first model organisms to study the actions of the most infamous teratogen, thalidomide (Jurand, 1966; Vargesson, 2009; Davey et al., 2018).
Figure 1. Key developmental structures of the chicken embryo and their timings. (A) The chicken embryo develops rapidly, the developing heart, limbs, eyes and brain can be used to evaluate teratogenic potential of teratogens such as thalidomide and Zika virus. By HH Stage 11 (Embryonic day E1.5-2), brain vesicles are developing and exposure to potential teratogens that might affect brain development may confirm their harmfulness, which become more evident by HH Stages 27 - 30. By HH Stage 18 (E3), limb buds can be observed and used to test substances with potential to affect limb development, which can be observed throughout development and confirmed by HH Stage 35 (E9-9.5), when cartilage elements can be better visualized. (B) Examples of teratogenic exposure and their effects on the development of chicken embryo; ZIKV induces to brain defects (white arrows; described previously in Wachholz et al., 2021) and CPS49, an antiangiogenic analog of thalidomide, which causes limb defects with reduction or absence of cartilage elements (black arrows; described previously in Therapontos et al., 2009). Images in B are from archives from Lucas Fraga’s Lab (ZIKV) and Neil Vargesson’s Lab (CPS49). BV, Brain Vesicles; NT, Neural Tube; FL, Forelimb; HL, Hindlimb; Te, telencephalon; Me, Mesencephalon; Ht, Heart; OV, Otic Vesicle.
The importance, influence and wide use of the chicken embryo is due to the fact that they are easy to manipulate and to maintain, they are a large embryo and thus, easy to visualize live and in ovo and follow development throughout gestation. They are also low cost and can be obtained in large numbers. By using chicken embryos, it is possible to analyze the development macroscopically and without embryonic and/or maternal sacrifice, which makes the analyses easier and faster when compared to other models that need long processing procedures. The embryo is isolated from its mother in an egg, and develops rapidly and is fully formed by day 10 and hatches around day 21. Together this makes the chicken embryo a very favorable model organism and supports the “3Rs”—the replacement, refinement and reduction of animals in research, as there is no need to euthanize the mother to obtain embryos, unlike mammalian species (Beedie et al., 2017; Vargesson and Fraga, 2017; Davey et al., 2018).
It is important to highlight that there are differences between chicken and mammalian embryo development. Chicken embryo development is external to the body in a self-contained egg with a yolk sac, which contains nutrients and molecules with a maternal origin. Unlike mammals, including humans, where the embryo develops inside the body, with a placenta supplying nutrients, and as there is also a maternal liver, means drugs can also be metabolized before arriving at the embryo. The chicken embryo not having a maternal metabolism allows scientists to understand the effect of some compounds in the embryo with the absence of maternal influence as well as help determine if a drug’s action requires maternal metabolism. Phenytoin, for instance, is an anti-epileptic drug that exerts its teratogenic effects through its arenes oxides metabolites (Spielberg et al., 1981; Strickler et al., 1985). Chicken embryos present with neural tube defects when they are exposed to phenytoin (Temiz et al., 2009). This suggests that the effect of phenytoin is not related exclusively to maternal metabolism and, therefore, reinforces the usefulness of the chicken embryo model. In addition, because of species-specificity of teratogenesis, some agents are not teratogenic in rodents, such as thalidomide (Vargesson, 2019). This is why chickens (and other species) can and have helped work out the actions of these drugs and confirm their safety (Vargesson, 2015). Therefore, as a method of understanding how a drug acts and determining its potential to cause teratogenesis, the chicken embryo remains powerful.
Chicken embryo developmental stages were extensively described by Hamburger and Hamilton (1951), and which are used today when studying chicken embryo development. Their description and delineation of a system of stages also help to compare chicken embryo development with other animal species and also human development, allowing research in human congenital anomalies to be performed in this model. For example, following the first 3 days of development when gastrulation and neurulation occurs, heart development quickly follows (Hamburger and Hamilton, 1951). Followed rapidly from 3 days, by the limb buds, together with the formation of other organs like eyes, ear and brain (Hamburger and Hamilton, 1951; Davey et al., 2018; Vilches-Moure, 2019; Figure 1). Together with the comparable embryology and physiology, there is a high genome conservation between mammals and chicken. Furthermore, the chicken genome is sequenced (Wallis et al., 2004).
One of the limitations of the use of chicken embryos is its relative lack of genetic tractability, compared to rodents. This is due to fertilization and early developmental events occurring inside the hen, followed by the egg shell being produced before being laid. This makes techniques like targeted gene knockouts through homologous recombination very difficult. However, it is possible to misexpress genes using the RCAS virus system (Logan and Tabin, 1998) and inhibit genes using RNAi (Krull, 2004). Also, more recently genomic editing techniques using CRISPR/Cas9 have started to be used chicken embryos, allowing targeted gene knockdowns (Williams et al., 2018; Chojnacka-Puchta and Sawicka, 2020). Taken all together, these techniques reinforce the usefulness of the chicken embryo in development, how drugs affect development and also genomic and molecular analyses (Burt et al., 1999; Stern, 2018).
The Chicken Embryo in the Evaluation and Understanding of Teratogens and Drug Safety
The development of a new drug requires different steps and an important one is the prediction of the potential teratogenic effects during development (Beedie et al., 2017). In preclinical trials, drugs in development are tested in pregnant animals, more frequently in mammals, which have a more similar physiology to humans. Since the thalidomide tragedy and the discovery of the species-specificity property of teratogenesis, it is necessary to perform drug screening in more than one species, including a rodent and a non-rodent, to attest its safety during development (Vargesson, 2013). Presently, testing of new drugs is mainly carried out in rodents and rabbits. However, chicken embryos have proved useful to understand actions of drugs linked to causing developmental problems and understanding a suspected teratogens mechanism of action, for example, thalidomide (Jurand, 1966; Knobloch et al., 2007; Therapontos et al., 2009; Vargesson, 2015; Beedie et al., 2016a,b). In addition, the advantage of live and in vivo observations of the chicken embryo following drug exposure, allows scientists to understand the drugs actions when applied at different timepoints and concentrations and drug actions can be followed throughout development. Chicken embryos are also being used as a preclinical screen to ascertain potential actions/side-effects of new drugs as well as screen drugs, for example thalidomide, phenytoin, ethanol, to understand their actions (Beedie et al., 2015, 2016a,b; Davey et al., 2018). This can (i) help reduce the number of rodents required in preliminary drug screening, as studies in the chicken embryo may indicate harmful effects and thus, not to be followed up in rodents; and (ii) give some insight into potential mechanisms of action of the drug as well as safety.
The chicken embryo enables analysis of the effects of a drug throughout development (and live and in ovo) including through early stages of organogenesis (Beedie et al., 2017), which is difficult in models such as rodents. Effects of drugs/compounds/agents can also be followed throughout development. As studies of the phenotypic spectrum and teratogenic risk of an agent in humans are limited to epidemiological analyses, this can be carried out in the chicken embryo as can a dose-response analysis and observation of the effects of varying the timing of exposure upon development, to determine the most sensitive time of development for each agent. This further underlines the importance of the chicken embryo as an excellent experimental model to follow and determine the risks of a teratogen (Wachholz et al., 2021).
For example, the chicken embryo model can be used to mimic human phenotypes after teratogen exposure, as it is the recent case of Zika virus. Wachholz et al. (2021) was able to mimic the microcephaly phenotype observed in humans after Zika virus infection during development in chicken embryos using a non-invasive method of infection. Chicken embryos have been used as a model for ZIKV infections since 1951 (Taylor, 1952) and today there are multiple research groups using the chicken embryo as a model of Congenital Zika Syndrome (Goodfellow et al., 2016; Willard et al., 2017; Thawani et al., 2018, 2020; Wachholz et al., 2021).
Some of the drugs/medicines that have been studied in chicken embryos to identify potential and/or understand teratogenic actions include thalidomide and thalidomide analogs including pomalidomide and tetrafluorinated thalidomide analogs with anti-cancer properties (Kemper and Berger, 1962; Kemper, 1963; Jurand, 1966; Tamilarasan et al., 2006; Knobloch et al., 2007; Therapontos et al., 2009; Vargesson, 2009; Ito et al., 2010; Mahony et al., 2013; Vargesson, 2019; Beedie et al., 2015, 2016a); the new-generation anti-epileptic medication Levetiracetam (Tureci et al., 2011); the anti-epileptic medicine sodium valproate (Whitsel et al., 2002); as well as anti-angiogenic anti-cancer compounds (Beedie et al., 2015, 2016a,b; Table 1). The chicken Chorioallantoic Membrane (CAM) has been also used to screen the anti-tumorigenic activity of overexpressed proteins (Valiulytë et al., 2019) and plays an important role in other cancer and cardiovascular studies, including bioengineering (Warnock et al., 2013; Kain et al., 2014; Nowak-Sliwinska et al., 2014).
Table 1. Morphological phenotypes observed after exposure of chicken embryos to teratogens.
Other examples of teratogens studied in chickens include studies looking at valproic acid exposure which can cause neural tube defects in the chicken embryo, together with cardiovascular anomalies (Whitsel et al., 2002; Hsieh et al., 2012, 2014). Limb and skeletal anomalies are also observed after exposure of valproic acid and retinoic acid (Tamarin et al., 1984; Whitsel et al., 2002). Congenital anomalies of the heart and cardiovascular system were also described after chicken embryo exposure to alcohol and retinoic acid (Fang et al., 1987; Whitsel et al., 2002). The exposure of thalidomide in chicken embryo has shown to cause limb anomalies, resembling the ones observed in humans, such as amelia (Stephens, 2009; Ito et al., 2010; Beedie et al., 2016a), phocomelia and radial dysplasia (Therapontos et al., 2009; Davey et al., 2018).
The chicken embryo has also been used to study treatments to prevent congenital anomalies caused by exposure of teratogens. For example, (i) damage caused by valproic acid, can be prevented or can be rescued by exposure with resveratrol, vitamin E, folic acid, n-acetylcysteine and vitamin C (Hsieh et al., 2012, 2014); (ii) damage caused by thalidomide has been prevented or rescued through application of nitric oxide (Siamwala et al., 2012); (iii) Cadmium induced damage can also be rescued by nitric oxide exposure (Veeriah et al., 2015).
Furthermore, the chicken embryo has also been used to study the consequences of teratogens in childhood and adult life (i.e., late-onset effects). For example, studies have used this model to analyze behavioral and memory impairments after prenatal exposure of factors, including ethanol, morphine, hypoxia, malnutrition, D-cycloserine, and others (Dose et al., 1995; Steele et al., 1996; Rodricks et al., 2004; Che et al., 2005; Rao and Chaudhuri, 2007; Smith et al., 2011; Mohammad et al., 2012). It has been observed that ethanol and morphine can affect long term memory in chicken when treated prenatally (Che et al., 2005; Rao and Chaudhuri, 2007). Along with memory, behavioral effects are also observed (Dose et al., 1995; Smith et al., 2011; Mohammad et al., 2012; Johnsson et al., 2016). Some of the outcomes observed included increase of fearfulness and tonic immobility and reduction of reflexive motor activity. Interestingly, the chicken was already used as a genomic model for tonic immobility and anxiety behavior (Johnsson et al., 2016; Fogelholm et al., 2019). Whether such late-onset effects are caused by brain malformations or if they occur in an independent manner, this remains to be further clarified. Nevertheless, chicken embryos are useful in investigating these outcomes.
Although the chicken embryo is a good model for understanding development and for understanding drug action it is not a standard system for pre-clinical drug screening. Consequently, most of the drugs studied in the chicken embryo the pharmacokinetic information is unclear. However, while the chicken embryo is not a standard tool for pharmacokinetics, it has been used in studies of toxicogenomics related to environmental exposure of bisphenol A alternatives, organic flame retardants and 6-OH-BDE47, which is a Hydroxylated polybrominated diphenyl ether (Peng et al., 2016; Pagé-Larivière et al., 2018; Sharin et al., 2021), indicating this is an area of expansion in the chicken embryo field, and which would further enhance its use in understanding pharmacokinetics.
The Chicken Embryo and Understanding Mechanisms of Teratogenesis
While many teratogens have been identified that are known to cause birth defects, how they cause the birth defects has remained unclear. Given the advantages of the chicken embryo, many teratogenic agents mechanistic bases have begun to be identified and include thalidomide, valproic acid, alcohol, cocaine, nicotine, retinoic acid and cadmium just to mention a few (Wiens et al., 1992; Venturini and Sparber, 2001; Cullinane et al., 2009; Therapontos et al., 2009; Ito et al., 2010; Hsieh et al., 2012; Yamamoto et al., 2012; El-Beltagy et al., 2015). Understanding the mechanisms of teratogenicity of a factor can shed light on the biological action of the compound as well as how it causes congenital anomalies, which can lead to potential ways of making safer drugs. In addition, the more we understand how congenital anomalies occur strategies of prevention can be determined.
Using chicken embryos, it was shown that one of the effects of alcohol on embryo development is due to the activation of a G-protein and a calcium-dependent mechanism of apoptosis (Table 2). This process was observed to cause effects in the brain and neural tube (Garic-Stankovic et al., 2005; Flentke et al., 2014). Chicken embryo exposure with alcohol was further used to understand the malformations observed in Fetal Alcohol Syndrome (FAS), for example, the craniofacial anomalies (Smith, 2008). Therefore, the chicken embryo is a good model to understand how organs and tissues are affected and which molecular pathways are disrupted (Garic-Stankovic et al., 2005; Smith, 2008; Flentke et al., 2014).
Table 2. Examples of mechanisms of teratogenesis of some teratogens using chicken embryos as experimental models.
The chicken embryo is also known as one of the models that has helped to understand how thalidomide caused such severe damage to the human embryo. While the precise mechanisms remain to be fully determined, of the many proposed mechanisms, there are three which are considered more likely to be the cause of thalidomide’s teratogenicity (D’Amato et al., 1994; Knobloch et al., 2007, 2017; Therapontos et al., 2009; Ito et al., 2010; Vargesson, 2013, 2015, 2019; Vargesson and Hootnick, 2017). They include anti-angiogenesis, oxidative stress induction and the binding of thalidomide to a protein named Cereblon. The chicken embryo demonstrated the antiangiogenic potential of thalidomide as a cause for limb deformities (Therapontos et al., 2009; Vargesson, 2009; Davey et al., 2018). Furthermore, the oxidative stress and cell death induction mechanism was tested in chicken embryos, where following thalidomide exposure upregulation of bone morphogenetic protein (bmp) and Dickkopf WNT Signaling Pathway Inhibitor 1 (dkk1) genes, involved in cell death was observed (Knobloch et al., 2007). Other studies in chicken embryos have also observed the downregulation of fgf10 and fgf8 mRNA, and induction of apoptosis (Knobloch et al., 2007; Therapontos et al., 2009; Ito et al., 2010). More recently the binding of thalidomide to Cereblon protein was first described using the chicken embryo as one of the approaches (Ito et al., 2010). Cereblon is a ubiquitin ligase whose function is to tag and remove unwanted molecules. The binding of thalidomide with Cereblon results in a disruption of cellular signaling. Precisely how the thalidomide/Cereblon complex causes the actual tissue damage is unclear, and there is also evidence that thalidomide may too be acting in a cereblon-independent mechanism, particularly with respect to thalidomide’s actions on the blood vessels (Beedie et al., 2020; Peach et al., 2020).
The chicken embryo has also shed light on how Valproic acid, used in humans to treat epilepsy, can cause embryonic malformations. In chicken embryos exposed to Valproic acid, damage to the embryo is rapidly observed (notably to limbs and eyes) through inhibition of angiogenesis, induction of oxidative stress and inhibition of histone deacetylase and key genes involved in tissue development including Pax2 and Pax6 (Whitsel et al., 2002; Chuang et al., 2012; Hsieh et al., 2012; Table 2).
Finally, although the molecular mechanisms of ZIKV teratogenesis are still to be fully determined, some important advances have been made using chicken embryos to understand how exposure to ZIKV during development causes malformations and the molecular basis of this. The first experiments aiming to understand the teratogenesis of ZIKV using as experimental models chicken embryos showed microcephaly, reduction on the head size, indicating disrupted brain growth, reassembling the CZS patients phenotype and giving a clue of which molecular mechanism could be involved (Thawani et al., 2018). Thawani et al. (2018) have demonstrated that ZIKV impairs the expression of important signaling molecules such as shh, bmp7, and fgf8 in specific regions of the developing brain. Such findings are important to increase knowledge about this recently discovered human teratogen, however, further studies are necessary to better define the mechanisms of teratogenesis of this virus.
Conclusion and Perspectives
The chicken embryo model allows live and in ovo studies and analyses throughout development to define and evaluate potential risks of compounds, determine teratogenic phenotypes and understand and describe the mechanism involved in its teratogenic process. All this is essential to create and design strategies, as well as preventive and therapeutic measures in order to avoid the occurrence of congenital anomalies. And equally important to help design safer drugs and medicines in the future.
Thalidomide is a great example of the importance of the chicken embryo, since it helped to understand the mechanisms of teratogenesis and to the identification and screening of safer alternative drugs (Jurand, 1966; Beedie et al., 2016a; Vargesson, 2019). ZIKV is also another good and recent example of this experimental model, since the chicken embryo is helping to understand the mechanisms of viral teratogenesis and to aid design prevention strategies to avoid the occurrence of malformations through the screening of new drugs aimed at ameliorating the ZIKV actions on the embryo.
Finally, the knowledge obtained through chicken embryos permits the discovery and testing of new drugs capable of avoiding or to prevent phenotypes caused by exposure to teratogenic agents during development.
Author Contributions
All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.
Funding
NV lab funded by Royal Society, Wellcome Trust, Sarcoma UK, NIH. LF lab funded by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (grant no. 424362/2018-0), Fundo de Incentivo a Pesquisa e Eventos (FIPE) of the Hospital de Clínicas de Porto Alegre (HCPA) (grant nos. 2019-0649 and 2017-0342), and PROPESQ/UFRGS through “Recently Hired Professors” (Call 001/2019).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
We would like to thank all previous researchers that established chicken embryos as a really important and respected experimental model to the teratology field throughout history. We would like to thank Sophia Martins Simon de Matos for technical assistance on Figure 1 drawing.
References
Baeten, J. M., Bukusi, E. A., and Lambe, M. (2001). Pregnancy complications and outcomes among overweight and obese nulliparous women. Am. J. Public Health 91, 436–440. doi: 10.2105/ajph.91.3.436
Barker, D. J., and Osmond, C. (1986). Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1, 1077–1081. doi: 10.1016/s0140-6736(86)91340-1
Beedie, S. L., Diamond, A. J., Fraga, L. R., Figg, W. D., and Vargesson, N. (2017). Vertebrate embryos as tools for anti-angiogenic drug screening and function. Reprod. Toxicol. 70, 49–59. doi: 10.1016/j.reprotox.2016.11.013
Beedie, S. L., Huang, P. A., Harris, E. M., Strope, J. D., Mahony, C., Chau, C. H., et al. (2020). Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs. FASEB J. 34, 11395–11404. doi: 10.1096/fj.201903060RR
Beedie, S. L., Peer, C. J., Pisle, S., Gardner, E. R., Mahony, C., Barnett, S., et al. (2015). Anticancer properties of a novel class of tetrafluorinated thalidomide analogues. Mol. Cancer Ther. 14, 2228–2237. doi: 10.1158/1535-7163.MCT-15-0320
Beedie, S. L., Rore, H. M., Barnett, S., Chau, C. H., Luo, W., Greig, N. H., et al. (2016a). In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems. Oncotarget 7, 33237–33245. doi: 10.18632/oncotarget.8909
Beedie, S. L., Mahony, C., Walker, H. M., Chau, C. H., Figg, W. D., and Vargesson, N. (2016b). Shared mechanism of teratogenicity of anti-angiogenic drugs identified in the chicken embryo model. Sci. Rep. 22:30038. doi: 10.1038/srep30038
Brent, R. L. (2001). The cause and prevention of human birth defects: what have we learned in the past 50 years? Congenital. Anomalies 41, 3–21.
Burt, D. W., Bruley, C. K., Dunn, I., Jones, C. T., Ramage, A., Law, A. S., et al. (1999). Dynamics of chromosome evolution: Clues from comparative gene mapping in birds and mammals. Nature 402, 411–413. doi: 10.1038/46555
Cairns, D. M., Boorgu, D. S. S. K., Levin, M., and Kaplan, D. L. (2018). Niclosamide rescues microcephaly in a tollhumanized in vivo model of Zika infection using human induced neural stem cells. Biol. Open 7:bio031807. doi: 10.1242/bio.031807
Calkins, K., and Devaskar, S. U. (2011). Fetal origins of adult disease. Curr. Probl. Pediatr. Adolesc. Health Care 41, 158–176. doi: 10.1016/j.cppeds.2011.01.001
Cambell, S. (2003). Prenatal cocaine exposure and neonatal/infant outcomes. Neonatal Netw. 22, 19–21. doi: 10.1891/0730-0832.22.1.19
Cassina, M., Salviati, L., Di Gianantonio, E., and Clementi, M. (2012). Genetic susceptibility to teratogens: state of the art. Reprod. Toxicol. 34, 186–191. doi: 10.1016/j.reprotox.2012.05.004
Che, Y., Sun, H., Tan, H., Peng, Y., Zeng, T., and Ma, Y. (2005). The effect of prenatal morphine exposure on memory consolidation in the chick. Neurosci. Lett. 380, 300–304. doi: 10.1016/j.neulet.2005.01.061
Chojnacka-Puchta, L., and Sawicka, D. (2020). CRISPR./Cas9 gene editing in a chicken model: current approaches and applications. J. Appl. Genet. 61, 221–229. doi: 10.1007/s13353-020-00537-9
Christianson, A., Howson, C. P., and Modell, B. (2006). March of Dimes Global Report on birth defects: The hidden toll of dying and disabled children. New York: March of Dimes Birth Defects Foundation, White Plains.
Chuang, C. M., Chang, C. H., Wang, H. E., Chen, K. C., Peng, C. C., Hsieh, C. L., et al. (2012). Valproic acid downregulates RBP4 and elicits hypervitaminosis A-teratogenesis–a kinetic analysis on retinol/retinoic acid homeostatic system. PLoS One 7:e43692. doi: 10.1371/journal.pone.0043692
Cugola, F. R., Fernandes, I. R., Russo, F. B., Freitas, B. C., Dias, J. L., Guimarães, K. P., et al. (2016). The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534, 267–271. doi: 10.1038/nature18296
Cullinane, J., Bannigan, J., and Thompson, J. (2009). Cadmium teratogenesis in the chick: period of vulnerability using the early chick culture method, and prevention by divalent cations. Reprod. Toxicol. 28, 335–341. doi: 10.1016/j.reprotox.2009.05.069
D’Amato, R. J., Loughnan, M. S., Flynn, E., and Folkman, J. (1994). Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. U S A. 91, 4082–4085.
Davey, M. G., and Tickle, C. (2007). The chicken as a model for embryonic development. Cytogenet. Genome Res. 117, 231–239. doi: 10.1159/000103184
Davey, M. G., Towers, M., Vargesson, N., and Tickle, C. (2018). The chick limb: embryology, genetics and teratology. Int. J. Dev. Biol. 62, 85–95. doi: 10.1387/ijdb.170315CT
de Araújo, T. V. B., Rodrigues, L. C., de Alencar Ximenes, R. A., de Barros Miranda-Filho, D., Montarroyos, U. R., de Melo, A. P. L., et al. (2016). Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. Lancet Infect. Dis. 16, 1356–1363. doi: 10.1016/S1473-3099(16)30318-8
Del Campo, M., Feitosa, I. M., and Ribeiro, E. M. (2017). Horovitz DD, Pessoa AL, França GV et al. Zika embryopathy task force-Brazilian society of medical genetics ZETF-SBGM. The phenotypic spectrum of congenital Zika syndrome. Am. J. Med. Genet. A 173, 841–857. doi: 10.1002/ajmg.a.38170
Dose, J. M., Caton, I. B., and Zolman, J. F. (1995). Physiological and behavioral effects of early embryonic exposure to ethanol and cocaine in the young chick. Neurotoxicol. Teratol. 17, 49–55. doi: 10.1016/0892-0362(94)00052-f
El-Beltagy, A. F., Abou-El-Naga, A. M., and Sabry, D. M. (2015). Neurotoxicological effects of nicotine on the embryonic development of cerebellar cortex of chick embryo during various stages of incubation. Tissue Cell 47, 506–514. doi: 10.1016/j.tice.2015.07.002
Ema, M., Naya, M., Yoshida, K., and Nagaosa, R. (2010). Reproductive and developmental toxicity of hydrofluorocarbons used as refrigerants. Reprod. Toxicol. 29, 125–131. doi: 10.1016/j.reprotox.2009.11.005
Fang, T. T., Bruyere, H. J. Jr., Kargas, S. A., Nishikawa, T., Takagi, Y., and Gilbert, E. F. (1987). Ethyl alcohol-induced cardiovascular malformations in the chick embryo. Teratology 35, 95–103. doi: 10.1002/tera.1420350113
Fattibene, P., Mazzei, F., Nuccetelli, C., and Risica, S. (1999). Prenatal exposure to ionizing radiation: sources, effects and regulatory aspects. Acta Paediatr. 88, 693–702. doi: 10.1080/08035259950168919
Ferm, V. H., and Carpenter, S. J. (1967). Teratogenic effect of cadmium and its inhibition by zinc. Nature 216:1123. doi: 10.1038/2161123a0
Flentke, G. R., Garic, A., Hernandez, M., and Smith, S. M. (2014). CaMKII represses transcriptionally active β-catenin to mediate acute ethanol neurodegeneration and can phosphorylate β-catenin. J. Neurochem. 128, 523–535.
Fogelholm, J., Inkabi, S., Höglund, A., Abbey-Lee, R., Johnsson, M., Jensen, P., et al. (2019). Genetical genomics of tonic immobility in the chicken. Genes (Basel) 10:341. doi: 10.3390/genes10050341
Fraga, L. R., Diamond, A. J., and Vargesson, N. (2016). Thalidomide and birth defects. eLS 2016:26052. doi: 10.1002/9780470015902.a0026052
Garic-Stankovic, A., Hernandez, M. R., Chiang, P. J., Debelak-Kragtorp, K. A., Flentke, G. R., Armant, D. R., et al. (2005). Ethanol triggers neural crest apoptosis through the selective activation of a pertussis toxin-sensitive G protein and a phospholipase Cbeta-dependent Ca2+ transient. Alcohol Clin. Exp. Res. 29, 1237–1246. doi: 10.1097/01.alc.0000172460.05756.d9
Giles, S., Boehm, P., Brogan, C., and Bannigan, J. (2008). The effects of ethanol on CNS development in the chick embryo. Reprod. Toxicol. 25, 224–230. doi: 10.1016/j.reprotox.2007.11.014
Goodfellow, F. T., Tesla, B., Simchick, G., Zhao, Q., Hodge, T., Brindley, M. A., et al. (2016). Zika virus induced mortality and microcephaly in chicken embryos. Stem Cells Dev. 25, 1691–1697. doi: 10.1089/scd.2016.0231
Grant, A., Ponia, S. S., Tripathi, S., Balasubramaniam, V., Miorin, L., Sourisseau, M., et al. (2016). Zika virus targets human STAT2 to inhibit type I interferon signaling. Cell Host Microbe 19, 882–890. doi: 10.1016/j.chom.2016.05.009
Gregg, N. M. (1941). Congenital cataract following german measles in the mother. Trans. Ophthalmol. Soc. Australia 3, 35–46.
Hale, F. (1935). The relation of vitamin A to anophthalmos in pigs. Am. J. Ophthalmol. 18, 1087–1093.
Hamburger, V., and Hamilton, H. L. (1951). A series of normal stages in the development of the chick embryo. J. Morphol. 88, 49–92.
Holbrook, B. D. (2016). The effects of nicotine on human fetal development. Birth Defects Res. C Embryo Today 108, 181–192. doi: 10.1002/bdrc.21128
Hsieh, C. L., Chen, K. C., Ding, C. Y., Tsai, W. J., Wu, J. F., and Peng, C. C. (2013). Valproic acid substantially downregulated genes folr1, IGF2R, RGS2, COL6A3, EDNRB, KLF6, and pax-3, N-acetylcysteine alleviated most of the induced gene alterations in chicken embryo model. Rom. J. Morphol. Embryol. 54, 993–1004.
Hsieh, C. L., Chen, K. C., Lin, P. X., Peng, C. C., and Peng, R. Y. (2014). Resveratrol and vitamin E rescue valproic acid-induced teratogenicity: the mechanism of action. Clin. Exp. Pharmacol. Physiol. 41, 210–219. doi: 10.1111/1440-1681.12205
Hsieh, C. L., Wang, H. E., Tsai, W. J., Peng, C. C., and Peng, R. Y. (2012). Multiple point action mechanism of valproic acid-teratogenicity alleviated by folic acid, vitamin C, and N-acetylcysteine in chicken embryo model. Toxicology 291, 32–42. doi: 10.1016/j.tox.2011.10.015
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., et al. (2010). Identification of a primary target of thalidomide teratogenicity. Science 327, 1345–1350. doi: 10.1126/science.1177319
Janer, G., Slob, W., Hakkert, B. C., Vermeire, T., and Piersma, A. H. (2008). A retrospective analysis of developmental toxicity studies in rat and rabbit: what is the added value of the rabbit as an additional test species? Regul. Toxicol. Pharmacol. 50, 206–217. doi: 10.1016/j.yrtph.2007.11.007
Johnsson, M., Williams, M. J., Jensen, P., and Wright, D. (2016). Genetical genomics of behavior: A novel chicken genomic model for anxiety behavior. Genetics 202, 327–340. doi: 10.1534/genetics.115.179010
Jurand, A. (1966). Early changes in limb buds of chick embryos after thalidomide treatment. J. Embryol. Exp. Morphol. 16, 289–300.
Kain, K. H., Miller, J. W., Jones-Paris, C. R., Thomason, R. T., Lewis, J. D., Bader, D. M., et al. (2014). The chick embryo as an expanding experimental model for cancer and cardiovascular research. Dev. Dyn. 243, 216–228. doi: 10.1002/dvdy.24093
Kemper, F., and Berger, H. (1962). Changes in the blood of chicks under the influence of thalidomide. Z Gesamte Exp. Med. 136, 86–96.
Kim, J. H., and Scialli, A. R. (2011). Thalidomide: the tragedy of birth defects and the effective treatment of disease. Toxicol. Sci. 122, 1–6. doi: 10.1093/toxsci/kfr088
Knobloch, J., Jungck, D., and Koch, A. (2017). The molecular mechanisms of thalidomide teratogenicity and implications for modern medicine. Curr. Mol. Med. 17, 108–117. doi: 10.2174/1566524017666170331162315
Knobloch, J., Shaughnessy, J. D. Jr., and Rüther, U. (2007). Thalidomide induces limb deformities by perturbing the Bmp/Dkk1/Wnt signaling pathway. FASEB J. 21, 1410–1421. doi: 10.1096/fj.06-7603com
Krull, C. E. (2004). A primer on using in ovo electroporation to analyze gene function. Dev. Dyn. 229, 433–439. doi: 10.1002/dvdy.10473
Léonard, A., Jacquet, P., and Lauwerys, R. R. (1983). Mutagenicity and teratogenicity of mercury compounds. Mutat. Res. 114, 1–18. doi: 10.1016/0165-1110(83)90017-9
Lewandoski, M., Sun, X., and Martin, G. R. (2000). Fgf8 signalling from the AER is essential for normal limb development. Nat. Genet. 26, 460–463. doi: 10.1038/82609
Logan, M., and Tabin, C. (1998). Targeted gene misexpression in chick limb buds using avian replication-competent retroviruses. Methods 14, 407–420. doi: 10.1006/meth.1998.0595
Mahony, C., Erskine, L., Niven, J., Greig, N. H., Figg, W. D., and Vargesson, N. (2013). Pomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitro. Proc. Natl. Acad. Sci. U S A. 110, 12703–12708. doi: 10.1073/pnas.1307684110
Mahony, C., and Vargesson, N. (2013). Molecular analysis of regulative events in the developing chick limb. J. Anat. 223, 1–13. doi: 10.1111/joa.12060
Marrs, C., Olson, G., Saade, G., Hankins, G., Wen, T., Patel, J., et al. (2016). Zika Virus and Pregnancy: A review of the literature and clinical considerations. Am. J. Perinatol. 33, 625–639. doi: 10.1055/s-0036-1580089
Mohammad, F. K., Faris, G. A., and Al-Zubeady, A. Z. (2012). Developmental and behavioral effects of medetomidine following in ovo injection in chicks. Neurotoxicol. Teratol. 34, 214–218. doi: 10.1016/j.ntt.2011.09.006
Moore, K. L., Persaud, T. V. N., and Torchia, M. G. (2019). The developing human: clinically oriented embryology. Philadelphia, PA: Saunders/Elsevier.
Nowak-Sliwinska, P., Segura, T., and Iruela-Arispe, M. L. (2014). The chicken chorioallantoic membrane model in biology, medicine and bioengineering. Angiogenesis 17, 779–804. doi: 10.1007/s10456-014-9440-7
Osmond, M. K., Butler, A. J., Voon, F. C., and Bellairs, R. (1991). The effects of retinoic acid on heart formation in the early chick embryo. Development 113, 1405–1417.
Pagé-Larivière, F., Chiu, S., Jones, S. P., Farhat, A., Crump, D., and O’Brien, J. M. (2018). Prioritization of 10 organic flame retardants using an avian hepatocyte toxicogenomic assay. Environ. Toxicol. Chem. 37, 3134–3144. doi: 10.1002/etc.4260
Peach, M. L., Beedie, S. L., Chau, C. H., Collins, M. K., Markolovic, S., Luo, W., et al. (2020). Antiangiogenic activity and in silico cereblon binding analysis of novel thalidomide analogs. Molecules. 25:5683. doi: 10.3390/molecules25235683
Peng, Y., Xia, P., Zhang, J., Villeneuve, D. L., Zhang, J., Wang, Z., et al. (2016). Toxicogenomic assessment of 6-OH-BDE47-induced developmental toxicity in chicken embryos. Environ. Sci. Technol. 50, 12493–12503. doi: 10.1021/acs.est.6b04467
Pleet, H., Graham, J. M. Jr., and Smith, D. W. (1981). Central nervous system and facial defects associated with maternal hyperthermia at four to 14 weeks’ gestation. Pediatrics 67, 785–789.
Rao, V., and Chaudhuri, J. D. (2007). Effect of gestational ethanol exposure on long-term memory formation in newborn chicks. Alcohol 41, 433–439. doi: 10.1016/j.alcohol.2007.04.012
Rasmussen, S. A., Jamieson, D. J., Honein, M. A., and Petersen, L. R. (2016). Zika virus and birth defects–reviewing the evidence for causality. N. Engl. J. Med. 374, 1981–1987. doi: 10.1056/NEJMsr1604338
Rodricks, C. L., Rose, I. A., Camm, E. J., Jenkin, G., Miller, S. L., and Gibbs, M. E. (2004). The effect of prenatal hypoxia and malnutrition on memory consolidation in the chick. Brain Res. Dev. Brain Res. 148, 113–119. doi: 10.1016/j.devbrainres.2003.10.008
Sandor, S. (1968). The influence of aethyl-alcohol on the developing chick embryo. II. Revue Roumaine d’Embryologie et de Cytology. Serie Cytol. 5, 167–172.
Sandor, S. T., and Elias, S. (1968). The influence of aethyl-alcohol on the development of the chick embryo. Rev. Roum. Embryol. Cytol. Ser. Embryol. 5, 51–76.
Schuler-Faccini, L., Sanseverino, M., Vianna, F., da Silva, A. A., Larrandaburu, M., and Marcolongo-Pereira, C. (2016). Zika virus: A new human teratogen? Implications for women of reproductive age. Clin. Pharmacol. Ther. 100, 28–30. doi: 10.1002/cpt.386
Sharin, T., Williams, K. L., Chiu, S., Crump, D., and O’Brien, J. M. (2021). Toxicity screening of bisphenol a replacement compounds: cytotoxicity and mRNA expression in primary hepatocytes of chicken and double-crested cormorant. Environ. Toxicol. Chem. 40, 1368–1378. doi: 10.1002/etc.4985
Shepard, T. H. (1994). “Proof” of human teratogenicity. Teratology 50, 97–98. doi: 10.1002/tera.1420500202
Siamwala, J. H., Veeriah, V., Priya, M. K., Rajendran, S., Saran, U., and Sinha, S. (2012). Nitric oxide rescues thalidomide mediated teratogenicity. Sci. Rep. 2:679. doi: 10.1038/srep00679
Smith, S. M. (2008). The avian embryo in fetal alcohol research. Methods Mol. Biol. 447, 75–84. doi: 10.1007/978-1-59745-242-7_6
Smith, S. M., Flentke, G. R., Kragtorp, K. A., and Tessmer, L. (2011). Ethanol exposure during the early first trimester equivalent impairs reflexive motor activity and heightens fearfulness in an avian model. Alcohol 45, 57–63. doi: 10.1016/j.alcohol.2010.06.001
Spielberg, S. P., Gordon, G. B., Blake, D. A., Goldstein, D. A., and Herlong, H. F. (1981). Predisposition to phenytoin hepatotoxicity assessed in vitro. N. Engl. J. Med. 305, 722–727. doi: 10.1056/NEJM198109243051302
Steele, R. J., Dermon, C. R., and Stewart, M. G. (1996). D-cycloserine causes transient enhancement of memory for a weak aversive stimulus in day-old chicks (Gallus domesticus). Neurobiol. Learn Mem. 66, 236–240. doi: 10.1006/nlme.1996.0064
Stephens, T. D. (2009). The effect of thalidomide in chicken embryos. Birth Defects Res. A Clin. Mol. Teratol. 85, 725–731. doi: 10.1002/bdra.20597
Stern, C. (2018). The chick model system: a distinguished past and a great future. Int. J. Dev. Biol. 62, 1–4. doi: 10.1387/ijdb.170270cs
Stern, C. D. (2004). The chick embryo–past, present and future as a model system in developmental biology. Mech. Dev. 121, 1011–1013. doi: 10.1016/j.mod.2004.06.009
Strickler, S. M., Dansky, L. V., Miller, M. A., Seni, M. H., Andermann, E., and Spielberg, S. P. (1985). Genetic predisposition to phenytoin-induced birth defects. Lancet 2, 746–749. doi: 10.1016/s0140-6736(85)90629-4
Tamarin, A., Crawley, A., Lee, J., and Tickle, C. (1984). Analysis of upper beak defects in chicken embryos following with retinoic acid. J. Embryol. Exp. Morphol. 84, 105–123.
Tamilarasan, K. P., Kolluru, G. K., Rajaram, M., Indhumathy, M., Saranya, R., and Chatterjee, S. (2006). Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells. BMC Cell. Biol. 7:17. doi: 10.1186/1471-2121-7-17
Taylor, R. M. (1952). Studies on certain viruses isolated in the tropics of Africa and South America; their growth and behavior in the embryonated hen egg. J. Immunol. 68, 473–494.
Temiz, C., Temiz, P., Demirel, A., Sayin, M., Umur, A. S., and Ozer, F. D. (2009). Effect of sodium phenytoin concentration on neural tube development in the early stages of chicken embryo development. J. Clin. Neurosci. 16, 307–311. doi: 10.1016/j.jocn.2007.12.007
Thawani, A., Sammudin, N. H., Reygaerts, H. S., Wozniak, A. N., Munnamalai, V., Kuhn, R. J., et al. (2020). Zika virus can directly infect and damage the auditory and vestibular components of the embryonic chicken inner ear. Dev. Dyn. 249, 867–883. doi: 10.1002/dvdy.176
Thawani, A., Sirohi, D., Kuhn, R. J., and Fekete, D. M. (2018). Zika virus can strongly infect and disrupt secondary organizers in the ventricular zone of the embryonic chicken brain. Cell Rep. 23, 692–700. doi: 10.1016/j.celrep.2018.03.080
Therapontos, C., Erskine, L., Gardner, E. R., Figg, W. D., and Vargesson, N. (2009). Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc. Natl. Acad. Sci. U S A. 106, 8573–8578. doi: 10.1073/pnas.0901505106
Towers, M., and Tickle, C. (2009). Growing models of vertebrate limb development. Development 136, 179–190. doi: 10.1242/dev.024158
Tureci, E., Asan, Z., Eser, M., Tanriverdi, T., Alkan, F., and Erdincler, P. (2011). The effects of valproic acid and levetiracetam on chicken embryos. J. Clin. Neurosci. 18, 816–820. doi: 10.1016/j.jocn.2010.11.005
Ujházy, E., Mach, M., Navarová, J., Brucknerová, I., and Dubovickı, M. (2012). Teratology - past, present and future. Interdiscip. Toxicol. 5, 163–168. doi: 10.2478/v10102-012-0027-0
Valiulytë, I., Curkûnavièiûtë, R., Ribokaitë, L., Kazlauskas, A., Vaitkevièiûtë, M., Skauminas, K., et al. (2019). The anti-tumorigenic activity of sema3C in the chick embryo chorioallantoic membrane model. Int. J. Mol. Sci. 20:5672. doi: 10.3390/ijms20225672
Vargesson, N. (2009). Thalidomide-induced limb defects: resolving a 50-year-old puzzle. Bioessays. 31, 1327–1336. doi: 10.1002/bies.200900103
Vargesson, N. (2013). Thalidomide embryopathy: an enigmatic challenge. ISRN Dev. Biol. 2013:241016. doi: 10.1155/2013/241016
Vargesson, N. (2015). Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res. C Embryo Today 105, 140–156. doi: 10.1002/bdrc.21096
Vargesson, N. (2019). The teratogenic effects of thalidomide on limbs. J. Hand. Surg. Eur. Vol. 44, 88–95. doi: 10.1177/1753193418805249
Vargesson, N., Clarke, J. D., Vincent, K., Coles, C., Wolpert, L., and Tickle, C. (1997). Cell fate in the chick limb bud and relationship to gene expression. Development 124, 1909–1918.
Vargesson, N., and Fraga, L. (2017). Teratogenesis: In eLS. Chichester: John Wiley & Sons, Ltd, 1–7.
Vargesson, N., and Hootnick, D. R. (2017). Arterial dysgenesis and limb defects: Clinical and experimental examples. Reprod. Toxicol. 70, 21–29. doi: 10.1016/j.reprotox.2016.10.005
Veeriah, V., Saran, U., Swaminathan, A., Balaguru, U. M., Thangaraj, P., and Nagarajan, S. (2015). Cadmium-induced embryopathy: nitric oxide rescues teratogenic effects of cadmium. Toxicol. Sci. 144, 90–104. doi: 10.1093/toxsci/kfu258
Venturini, L., and Sparber, S. B. (2001). Salicylate and cocaine: interactive toxicity during chicken mid-embryogenesis. Free Radic. Biol. Med. 30, 198–207. doi: 10.1016/s0891-5849(00)00455-x
Vergara, M. N., and Canto-Soler, M. V. (2012). Rediscovering the chick embryo as a model to study retinal development. Neural. Dev. 27:22. doi: 10.1186/1749-8104-7-22
Vilches-Moure, J. G. (2019). Embryonic chicken (Gallus gallus domesticus) as a model of cardiac biology and development. Comp. Med. 69, 184–203. doi: 10.30802/AALAS-CM-18-000061
Wachholz, G. E., Varela, A. P. M., Teixeira, T. F., de Matos, S. M. S., Rigon da Luz Soster, P., Vianna, F. S. L., et al. (2021). Zika virus-induced brain malformations in chicken embryos. Birth Defects Res. 113, 22–31. doi: 10.1002/bdr2.1813
Wallis, J. W., Aerts, J., Groenen, M. A., Crooijmans, R. P., Layman, D., Graves, T. A., et al. (2004). A physical map of the chicken genome. Nature 432, 761–764. doi: 10.1038/nature03030
Warkany, J., and Schrafenberger, E. (1946). Congenital malformations induced in rats by maternal vitamin A deficiency: I. Defects Eye. Arch. Ophthalmol. 35, 150–169. doi: 10.1001/archopht.1946.00890200155008
Warnock, G., Turtoi, A., Blomme, A., Bretin, F., Bahri, M. A., Lemaire, C., et al. (2013). In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: a new tool for oncology and radiotracer development. J. Nucl. Med. 54, 1782–1788. doi: 10.2967/jnumed.112.117150
Whitsel, A. I., Johnson, C. B., and Forehand, C. J. (2002). An in ovo chicken model to study the systemic and localized teratogenic effects of valproic acid. Teratology 66, 153–163. doi: 10.1002/tera.10093
Wiens, D. J., Mann, T. K., Fedderson, D. E., Rathmell, W. K., and Franck, B. H. (1992). Early heart development in the chick embryo: effects of isotretinoin on cell proliferation, alpha-actin synthesis, and development of contractions. Differentiation 51, 105–112. doi: 10.1111/j.1432-0436.1992.tb00686.x
Willard, K. A., Demakovsky, L., Tesla, B., Goodfellow, F. T., Stice, S. L., Murdock, C. C., et al. (2017). Zika virus exhibits lineage-specific phenotypes in cell culture, in Aedes aegypti mosquitoes, and in an embryo model. Viruses 9:383. doi: 10.3390/v9120383
Williams, J. F., Smith, V. C., and Committee On Substance Abuse. (2015). Fetal alcohol spectrum disorders. Pediatrics 136, e1395–e1406. doi: 10.1542/peds.2015-3113
Williams, R. M., Senanayake, U., Artibani, M., Taylor, G., Wells, D., Ahmed, A. A., et al. (2018). Genome and epigenome engineering CRISPR toolkit for in vivo modulation of cis-regulatory interactions and gene expression in the chicken embryo. Development 145:dev160333. doi: 10.1242/dev.160333
Wilson, J. G. (1973). Environment and Birth Defects (Environmental Science Series). London: Academic Pr.
World Health Organization. (2020a). Congenital anomalies. Available Online at: https://www.who.int/news-room/fact-sheets/detail/congenital-anomalies (accessed December 06, 2020).
World Health Organization. (2020b). Distribution of causes of death among children aged < 5 years (%). Available Online at: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/distribution-of-causes-of-death-among-children-aged-5-years-(-) (accessed December 06, 2020).
Keywords: congenital malformations, preclinical trials, gene expression, teratogens, embryonic anomalies, drug/medicine safety, ZIKV, thalidomide
Citation: Wachholz GE, Rengel BD, Vargesson N and Fraga LR (2021) From the Farm to the Lab: How Chicken Embryos Contribute to the Field of Teratology. Front. Genet. 12:666726. doi: 10.3389/fgene.2021.666726
Received: 10 February 2021; Accepted: 11 June 2021;
Published: 22 July 2021.
Edited by:
Elgion Lucio Silva Loreto, Federal University of Santa Maria, BrazilReviewed by:
Richard H. Finnell, Baylor College of Medicine, United StatesJeremy W. Chambers, Florida International University, United States
Copyright © 2021 Wachholz, Rengel, Vargesson and Fraga. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lucas Rosa Fraga, lrfraga@ufrgs.br
†These authors have contributed equally to this work and share first authorship